Svenska Handelsbanken Ab (Publ) Abbott Laboratories Transaction History

Svenska Handelsbanken Ab (Publ)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$108.84 - $128.23 $2.55 Million - $3 Million	-23,400 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$62.82 - $91.86 $1.47 Million - $2.15 Million	23,400 New	23,400 $1.85 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $1.84 Million - $2.05 Million	-23,400 Closed	0 $0
Q2 2019 Jul 30, 2019	BUY	$72.88 - $85.0 $211,352 - $246,500	2,900 Added 14.15%	23,400 $1.97 Million
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $1.36 Million - $1.64 Million	20,500 New	20,500 $1.64 Million

3,130

1.29B

8.43M

8.71M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $182B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Svenska Handelsbanken Ab (Publ), based on Form 13F filings with the SEC.

Stay updated on Svenska Handelsbanken Ab (Publ) with notifications on news.